51. Surveillance of molecular markers of antimalarial drug resistance in Plasmodium falciparum and Plasmodium vivax in Federally Administered Tribal Area (FATA), Pakistan
- Author
-
Usman Ayub Awan, Nadia Zeeshan, Hamza Zahid, Naeem Mahmood Ashraf, Aamer Ali Khattak, Waqas Ahmed, Adnan Yaqoob, Sana Gul, Sadia Alam, and Muhammad Faisal Nadeem
- Subjects
FATA ,RC955-962 ,Plasmodium vivax ,Plasmodium falciparum ,Drug Resistance ,Protozoan Proteins ,DHPS ,Drug resistance ,Biology ,Antimalarials ,symbols.namesake ,Chloroquine ,Arctic medicine. Tropical medicine ,parasitic diseases ,medicine ,Humans ,Antimalarial drug resistance ,Pakistan ,Malaria, Falciparum ,Artemisinin ,Sanger sequencing ,biology.organism_classification ,medicine.disease ,Virology ,Malaria ,Mutation ,symbols ,Original Article ,medicine.drug - Abstract
This molecular epidemiological study was designed to determine the antimalarial drug resistance pattern, and the genetic diversity of malaria isolates collected from a war-altered Federally Administered Tribal Area (FATA), in Pakistan. Clinical isolates were collected from Bajaur, Mohmand, Khyber, Orakzai and Kurram agencies of FATA region between May 2017 and May 2018, and they underwent DNA extraction and amplification. The investigation of gene polymorphisms in drug resistance genes (dhfr, dhps, crt, and mdr1) of Plasmodium falciparum and Plasmodium vivax was carried out by pyrosequencing and Sanger sequencing, respectively. Out of 679 PCR-confirmed malaria samples, 523 (77%) were P. vivax, 121 (18%) P. falciparum, and 35 (5%) had mixed-species infections. All P. falciparum isolates had pfdhfr double mutants (C59R+S108N), while pfdhfr/pfdhps triple mutants (C59R+S108N+A437G) were detected in 11.5% of the samples. About 97.4% of P. falciparum isolates contained pfcrt K76T mutation, while pfmdr1 N86Y and Y184F mutations were present in 18.2% and 10.2% of the samples. P. vivax pvdhfr S58R mutation was present in 24.9% of isolates and the S117N mutation in 36.2%, while no mutation in the pvdhps gene was found. Pvmdr1 F1076L mutation was found in nearly all samples, as it was observed in 98.9% of isolates. No significant anti-folate and chloroquine resistance was observed in P. vivax; however, mutations associated with antifolate-resistance were found, and the chloroquine-resistant gene has been observed in 100% of P. falciparum isolates. Chloroquine and sulphadoxine-pyrimethamine resistance were found to be high in P. falciparum and low in P. vivax. Chloroquine could still be used for P. vivax infection but need to be tested in vivo, whereas a replacement of the artemisinin combination therapy for P. falciparum appears to be justified.
- Published
- 2021